---
confidence_score: 0.95
created: 2026-01-03T17:55:39+0000
description: Adenosine triphosphate (ATP) is the universal energy currency of all
  living cells, providing the free energy for virtually all cellular processes including
  muscle contraction, nerve transmission, active transport, and biosynthesis. ATP
  is synthesized primarily by oxidative phosphorylation in mitochondria and substrate-level
  phosphorylation in glycolysis, with cellular turnover rates estimated at 10^9 to
  10^10 ATP molecules per day.
dg-home: false
dg-publish: true
evidence_level: 5
gardenUsername: e2euser79eab732
id: atp
permalink: /garden/e2euser79eab732/metabolite/atp/
provenance: curated
pubchem_id: '5957'
slug: atp
source: Manual
tags:
- metabolite
- nucleotide
- energy_metabolism
- mitochondrial
- bioenergetics
- universal_energy_currency
templateEngineOverride: njk
title: ATP
type: metabolite
updated: '2026-08-20T03:54:39.501850Z'
---

{% raw %}
<h1>ATP</h1>
<h2>Overview</h2>
<p>Adenosine triphosphate (ATP) is a nucleotide consisting of adenine, ribose, and three phosphate groups (molecular formula C10H16N5O13P3, molecular weight 507.18 Da). It serves as the universal energy currency of all known living organisms, from bacteria to humans. The free energy stored in the phosphoanhydride bonds — particularly the terminal bond between the beta and gamma phosphates — is released upon hydrolysis (ATP → ADP + Pi, deltaG ≈ -30.5 kJ/mol under standard cellular conditions) and used to drive virtually every energy-requiring process in the cell.</p>
<p>The human body synthesizes and hydrolyzes approximately 50-75 kg of ATP per day, though the total body ATP pool at any given moment is only about 50 grams. This extraordinary turnover rate reflects the continuous cycling between ATP (charged) and ADP (discharged) states. ATP cannot be stored in significant quantities — it must be continuously regenerated — making the efficiency of ATP production systems (mitochondrial oxidative phosphorylation, glycolysis) critical for cell survival.</p>
<p>ATP serves functions beyond energy transduction: it is a substrate for kinase-mediated signal transduction, an allosteric regulator of metabolic enzymes, a precursor for cyclic AMP (cAMP) and other signaling molecules, and an extracellular signaling molecule through purinergic (P2) receptors. This multifaceted role makes ATP the most central metabolite in biology.</p>
<h2>ATP Production</h2>
<h3>Oxidative Phosphorylation (Primary Pathway)</h3>
<p>The majority of cellular ATP (~90% in most tissues) is produced by oxidative phosphorylation in the inner mitochondrial membrane:</p>
<ul>
<li><strong>Electron transport chain (ETC):</strong> Complexes I-IV transfer electrons from NADH and FADH2 to molecular oxygen, pumping protons from the matrix to the intermembrane space and creating an electrochemical proton gradient (proton-motive force)</li>
<li><strong>ATP synthase (Complex V):</strong> The F1F0-ATP synthase harnesses the proton-motive force to phosphorylate ADP to ATP as protons flow back through the F0 channel. This rotary molecular machine produces approximately 3 ATP per rotation (one per beta subunit)</li>
<li><strong>P/O ratios:</strong> Approximately 2.5 ATP per NADH oxidized and 1.5 ATP per FADH2 oxidized</li>
<li><strong>Substrates:</strong> NADH from the TCA cycle, glycolysis, and beta-oxidation; FADH2 from the TCA cycle and beta-oxidation</li>
</ul>
<h3>Substrate-Level Phosphorylation</h3>
<p>ATP is also generated without oxygen through direct transfer of phosphate groups:</p>
<ul>
<li><strong>Glycolysis:</strong> 2 ATP net per glucose (phosphoglycerate kinase and pyruvate kinase steps)</li>
<li><strong>TCA cycle:</strong> 1 GTP (equivalent to ATP) per acetyl-CoA (succinyl-CoA synthetase step)</li>
<li><strong>Creatine kinase:</strong> Transfers phosphate from phosphocreatine to ADP, rapidly regenerating ATP in muscle, brain, and heart</li>
</ul>
<h3>Daily ATP Production Sources</h3>
<table>
<thead>
<tr>
<th>Fuel Source</th>
<th>ATP Yield Per Unit</th>
<th>Daily Contribution</th>
</tr>
</thead>
<tbody>
<tr>
<td>Glucose (oxidative)</td>
<td>~30-32 ATP/glucose</td>
<td>Major (brain, resting muscle)</td>
</tr>
<tr>
<td>Fatty acids (beta-oxidation)</td>
<td>~106 ATP/palmitate</td>
<td>Major (resting muscle, heart, liver)</td>
</tr>
<tr>
<td>Amino acids</td>
<td>Variable (8-25 ATP)</td>
<td>Minor (fasting, stress)</td>
</tr>
<tr>
<td>Ketone bodies</td>
<td>~21-22 ATP/acetoacetate</td>
<td>Significant during fasting/ketosis</td>
</tr>
<tr>
<td>Phosphocreatine</td>
<td>1 ATP/PCr</td>
<td>Buffering (muscle, brain)</td>
</tr>
</tbody>
</table>
<h2>ATP Consumption</h2>
<h3>Major Cellular ATP Consumers</h3>
<table>
<thead>
<tr>
<th>Process</th>
<th>% of Cellular ATP</th>
<th>Tissue Context</th>
</tr>
</thead>
<tbody>
<tr>
<td>Na+/K+-ATPase (ion gradients)</td>
<td>20-40%</td>
<td>All cells (especially neurons, kidney)</td>
</tr>
<tr>
<td>Protein synthesis</td>
<td>10-20%</td>
<td>All growing cells</td>
</tr>
<tr>
<td>Muscle contraction (myosin ATPase)</td>
<td>30-60%</td>
<td>Skeletal and cardiac muscle</td>
</tr>
<tr>
<td>Ca2+-ATPase (SERCA, PMCA)</td>
<td>5-15%</td>
<td>Muscle, neurons</td>
</tr>
<tr>
<td>Biosynthesis (DNA, lipids, glycogen)</td>
<td>5-10%</td>
<td>Liver, proliferating cells</td>
</tr>
</tbody>
</table>
<h3>The ATP Hydrolysis Reaction</h3>
<p>ATP + H2O → ADP + Pi (deltaG ≈ -30.5 kJ/mol under standard conditions; -50 to -65 kJ/mol in vivo)</p>
<p>Under extreme energy demand, ADP can be further hydrolyzed:<br />
ADP + H2O → AMP + Pi (via ATP synthase running in reverse, or myosin ATPase under load)</p>
<p>And AMP is degraded:<br />
AMP → Adenosine + Pi (via 5'-nucleotidase; adenosine exits cell as a signaling molecule)</p>
<h2>Energy Buffering Systems</h2>
<h3>Phosphocreatine/Creatine Kinase System</h3>
<p>The primary short-term ATP buffer in muscle, brain, and heart:</p>
<ul>
<li><strong>Creatine kinase reaction:</strong> ADP + Phosphocreatine ⇌ ATP + Creatine</li>
<li><strong>Buffering capacity:</strong> Maintains near-constant ATP levels during the first ~10 seconds of intense exercise</li>
<li><strong>Spatial buffering:</strong> Mitochondrial creatine kinase couples ATP production to phosphocreatine diffusion to sites of consumption, where cytosolic creatine kinase regenerates ATP locally</li>
<li><strong>Supplementation:</strong> Creatine supplementation increases total creatine/phosphocreatine pool, extending buffering capacity</li>
</ul>
<h3>Adenylate Kinase</h3>
<p>2 ADP ⇌ ATP + AMP — maintains ADP levels and generates AMP for AMPK signaling when energy is depleted.</p>
<h3>Glycolytic Buffering</h3>
<p>During high-intensity exercise, glycolytic flux can generate ATP anaerobically at rates exceeding oxidative phosphorylation (though yield per glucose is much lower).</p>
<h2>Regulation and Signaling</h2>
<h3>Energy Charge</h3>
<p>The energy charge of the cell is defined as: EC = ([ATP] + 0.5[ADP]) / ([ATP] + [ADP] + [AMP]). Most cells maintain EC between 0.8-0.95. Key regulatory enzymes are allosterically modulated by the energy charge:</p>
<ul>
<li><strong>High EC (energy-replete):</strong> Activates anabolic enzymes (acetyl-CoA carboxylase, PFK-1 is inhibited by ATP)</li>
<li><strong>Low EC (energy-depleted):</strong> Activates catabolic enzymes (PFK-2, AMPK), inhibits anabolic pathways</li>
</ul>
<h3>AMPK Activation</h3>
<p>When ATP consumption outpaces production, rising ADP is converted to AMP by adenylate kinase. AMP activates AMP-activated protein kinase (AMPK), which:</p>
<ul>
<li>Activates fatty acid oxidation, glucose uptake, autophagy, mitochondrial biogenesis</li>
<li>Inhibits fatty acid synthesis, protein synthesis (mTOR), cholesterol synthesis</li>
<li>Acts as the master cellular energy sensor</li>
</ul>
<h3>Purinergic Signaling</h3>
<p>Extracellular ATP and its breakdown products (ADP, AMP, adenosine) signal through purinergic receptors:</p>
<ul>
<li><strong>P2X receptors (ionotropic):</strong> ATP-gated cation channels; fast signaling in neurons and immune cells</li>
<li><strong>P2Y receptors (metabotropic):</strong> G-protein-coupled; ADP at P2Y12 mediates platelet activation</li>
<li><strong>Adenosine receptors (A1, A2A, A2B, A3):</strong> Modulate heart rate, vasodilation, inflammation, and neurotransmission</li>
</ul>
<h2>Clinical Significance</h2>
<h3>Mitochondrial Disease</h3>
<p>Defective oxidative phosphorylation in mitochondrial disorders (MELAS, MERRF, LHON, mitochondrial myopathies) impairs ATP production, causing energy failure in high-demand tissues (brain, muscle, heart, kidney).</p>
<h3>Ischemia and Reperfusion</h3>
<ul>
<li><strong>Ischemic injury:</strong> Oxygen deprivation halts oxidative phosphorylation; ATP depletion causes cellular acidosis, ion pump failure, and cell death</li>
<li><strong>Reperfusion injury:</strong> Sudden oxygen return can trigger mitochondrial permeability transition pore opening, catastrophic ATP depletion, and apoptosis/necrosis</li>
<li><strong>Ischemic preconditioning:</strong> Brief ischemic episodes upregulate protective mechanisms, preserving ATP levels during subsequent prolonged ischemia</li>
</ul>
<h3>Exercise and Performance</h3>
<ul>
<li>ATP demand during maximal exercise can increase 50-100x above resting levels</li>
<li>Creatine supplementation extends phosphocreatine buffering capacity, improving performance in repeated high-intensity efforts</li>
<li>Training adaptations increase mitochondrial density and oxidative ATP capacity</li>
</ul>
<h3>Cancer Metabolism</h3>
<p>The Warburg effect describes the preference of many cancer cells for aerobic glycolysis over oxidative phosphorylation for ATP production, despite the lower yield (2 vs. ~30 ATP/glucose). This supports rapid biomass production and avoids reactive oxygen species generation from mitochondria.</p>
<h3>Sepsis and Critical Illness</h3>
<p>Mitochondrial dysfunction in sepsis leads to impaired ATP production, and the ATP/ADP ratio correlates with disease severity and mortality.</p>
<h3>Neurodegeneration</h3>
<p>Impaired brain ATP production is implicated in Alzheimer's disease, Parkinson's disease, and ALS. Neurons are particularly vulnerable to ATP depletion due to their high metabolic demand and reliance on oxidative phosphorylation.</p>
<h2>Relationships</h2>
<h3>Produced By</h3>
<p>PRODUCED_BY::<a href="/garden/e2euser79eab732/metabolite/phosphocreatine/" class="internal-link">Phosphocreatine</a></p>
<h3>Converted To</h3>
<p>CONVERTED_TO::<a href="/garden/e2euser79eab732/metabolite/adp/" class="internal-link">ADP</a></p>
<h3>Regulates</h3>
<p>REGULATES::<a href="/garden/e2euser79eab732/protein/ampk/" class="internal-link">AMPK</a></p>
<h3>Participates In Pathways</h3>
<p>PARTICIPATES_IN_PATHWAY::<a href="/garden/e2euser79eab732/pathway/oxidative-phosphorylation/" class="internal-link">Oxidative Phosphorylation</a><br />
PARTICIPATES_IN_PATHWAY::<a href="/garden/e2euser79eab732/pathway/citric-acid-cycle/" class="internal-link">Citric Acid Cycle</a><br />
PARTICIPATES_IN_PATHWAY::<a href="/garden/e2euser79eab732/pathway/glycolysis/" class="internal-link">Glycolysis</a><br />
PARTICIPATES_IN_PATHWAY::<a href="/garden/e2euser79eab732/pathway/beta-oxidation/" class="internal-link">Beta-Oxidation</a></p>
<h3>Related Metabolites</h3>
<p>RELATED::<a href="/garden/e2euser79eab732/metabolite/adp/" class="internal-link">ADP</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/nadh/" class="internal-link">NADH</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/fadh2/" class="internal-link">FADH2</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/acetyl-coa/" class="internal-link">Acetyl-CoA</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/pyruvate/" class="internal-link">Pyruvate</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/coenzyme-a/" class="internal-link">Coenzyme A</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/alpha-ketoglutarate/" class="internal-link">Alpha-Ketoglutarate</a><br />
RELATED::<a href="/garden/e2euser79eab732/metabolite/ketone-bodies/" class="internal-link">Ketone Bodies</a></p>
<h3>Related Supplements</h3>
<p>RELATED::<a href="/garden/e2euser79eab732/supplement/magnesium/" class="internal-link">Magnesium</a><br />
RELATED::<a href="/garden/e2euser79eab732/supplement/creatine/" class="internal-link">Creatine</a><br />
RELATED::<a href="/garden/e2euser79eab732/supplement/coenzyme-q10/" class="internal-link">Coenzyme Q10</a><br />
RELATED::<a href="/garden/e2euser79eab732/supplement/nmn/" class="internal-link">NMN</a><br />
RELATED::<a href="/garden/e2euser79eab732/supplement/nicotinamide-riboside/" class="internal-link">Nicotinamide Riboside</a><br />
RELATED::<a href="/garden/e2euser79eab732/supplement/l-carnitine/" class="internal-link">L-Carnitine</a></p>
<h3>Related Proteins</h3>
<p>RELATED::<a href="/garden/e2euser79eab732/protein/sirt1/" class="internal-link">SIRT1</a></p>
<h3>Related Interventions</h3>
<p>RELATED::<a href="/garden/e2euser79eab732/intervention/red-light-therapy/" class="internal-link">Red Light Therapy</a></p>
<h3>Organelles</h3>
<p>LOCATED_IN::<a href="/garden/e2euser79eab732/cellularcomponent/mitochondria/" class="internal-link">Mitochondria</a></p>
<h2>References</h2>
<ul>
<li>Boyer PD. The ATP synthase--a splendid molecular machine. <em>Annu Rev Biochem.</em> 1997;66:717-749 (PMID: 9242922)</li>
<li>Abrahams JP, Leslie AG, Lutter R, Walker JE. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria. <em>Nature.</em> 1994;370(6491):621-628 (PMID: 8065448)</li>
<li>Burnstock G. Introduction to purinergic signaling. <em>Methods Mol Biol.</em> 2020;2041:1-15 (PMID: 31646477)</li>
<li>Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. <em>Annu Rev Biochem.</em> 1985;54:831-862 (PMID: 3896131)</li>
<li>Robergs RA, Ghiasvand F, Parker D. Biochemistry of exercise-induced metabolic acidosis. <em>Am J Physiol Regul Integr Comp Physiol.</em> 2004;287(3):R502-R516 (PMID: 15308499)</li>
<li>Madeira VMC. Overview of mitochondrial bioenergetics. <em>Methods Mol Biol.</em> 2012;810:1-6 (PMID: 22057557)</li>
</ul>

{% endraw %}